Information was received from multiple sources (manufacturer representative, healthcare provider, foreign) regarding a patient who w as implanted with an implantable neurostimulator (ins) for unknown indications for use.It was reported that the patient received a revision surgery of the device pocket where they moved the ins from being in the abdominal to the pectoral due to discomfort.During the surgery, the physician had to disconnect the lead extensions from the ins where she found the seal over the set screws detached from the ins.The seal had been loosened.The ins and seal would be returned to the manufacturer for analysis.The ins was replaced with a different model ins.There were no symptoms related to the seal issue.There were no known external factors that may have led or contributed to the issue.No diagnostics or troubleshooting was performed.Replacing the device resolved the issue.
|
H2.Correction: please note, codes b17, c20, and d14 no longer apply to this report.H3.The returned device (serial # (b)(6)) was subjected to a series of standard tests that include but is not limited to visual inspection, output and telemetry testing, and functional testing.Analysis identified that the implantable neurostimulator (ins) grommet was loose.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|